Insulin Delivery System Market GLOBAL INDUSTRY ANALYSIS, TRENDS, MARKET SIZE AND FORECASTS UP TO 2023
Insulin Delivery System Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
Š Infinium Global Research
Page 2
Insulin Delivery System Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
We have produced a new premium report Insulin Delivery System Market. The report covers the analysis of global as well as regional markets of Insulin Delivery System. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of Insulin Delivery System Market by product type (insulin pens, insulin jet injectors, syringes, insulin pumps), by end user (specialty diabetic clinics, hospitals, retail channels) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the Insulin Delivery System Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Insulin Delivery System Market are Becton, Dickinson and Company, Novo Nordisk A/S, Tandem Diabetes Care, Inc., Medtronic PLC, Sanofi, Animas Corporation (Johnson and Johnson), Insulet Corporation, Biocon Limited. According to the report the Global Insulin Delivery System Market is projected to grow at a CAGR between 5.0% and 5.5% in terms of value over the period of 2017-2023. For More Details Get Free Few Sample Pages of this Premium Report: https://www.infiniumglobalresearch.com/reports/sample-request/806 Growing Research and Development, Increasing Expenditure in Emerging Economies on Diabetes-Related Health are Likely to Bring More Opportunities to this Market Patient are moving from hospitals to specialty clinics, Users prefer syringes and insulin pens because of their low cost, refining policies for compensation, and availability, affordability of devices, are some of the key factor driving the growth of global insulin delivery system market Moreover, needle nervousness in patients affect the growth of the pen needles and syringes market, problems related with the reuse of pen needles and infusion sets are the key factors restraining the growth of this market. Growing research and development, increasing expenditure in emerging economies on diabetes-related health are likely to bring more opportunities to this market. Segments Covered in this Premium Report The report segments the insulin delivery system market by product type, by end user and by region. Market segmentation based on product type includes insulin pens, insulin jet injectors, syringes and insulin pumps. Specialty diabetic clinics, hospitals and retail channels are sub-segment of end user.
Š Infinium Global Research
Page 3
Insulin Delivery System Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
Asia Pacific Is Expected to Grow at the Highest CAGR Rate over the Forecast Period due the Improved Healthcare System The report provides regional analysis covering geographies such as Americas, Europe, AsiaPacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.Americas was the largest market among the geographies and contributed over 76% of the revenue in 2015. Moreover, The US was the largest contributor in terms of revenue in 2015 due to improvement in healthcare scheme such as offering compensation. Furthermore, Europe market is expected to grow steadily because better government support. Asia Pacific is expected to grow at the highest CAGR rate over the forecast period due the improved healthcare system. ROW region is expected to grow gradually over the forecast period. Companies Profiled: The companies covered in the report include ELI Lilly and Company, Ypsomed Holding AG, Becton, Dickinson and Company, Novo Nordisk A/S, Tandem Diabetes Care, Inc., Medtronic PLC, Sanofi, Animas Corporation (Johnson and Johnson), Insulet Corporation, Biocon Limited. Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-insulindelivery-system-market
Š Infinium Global Research
Page 4